相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review
C. M. Guo et al.
NEOPLASMA (2020)
Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer
Dalong Cao et al.
CANCER RESEARCH (2019)
miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
Duolu Li et al.
EXPERIMENTAL CELL RESEARCH (2019)
MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside
Sundas Fayyaz et al.
SEMINARS IN CANCER BIOLOGY (2019)
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2019)
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Anqi Lin et al.
MOLECULAR CANCER (2019)
PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
Xin Yao Qiu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c
Abisola Abisoye-Ogunniyan et al.
CANCER LETTERS (2018)
miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20
Tianshu Guo et al.
CELL BIOLOGY INTERNATIONAL (2018)
Lactoferricin B reverses cisplatin resistance in head and neck squamous cell carcinoma cells through targeting PD-L1
Pei Zhang et al.
CANCER MEDICINE (2018)
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial- mesenchymal transition and metastasis by controlling TIF1 gamma in non-small cell lung cancer
Longqiang Wang et al.
MOLECULAR CANCER (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets (vol 8, 9227, 2018)
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
Peixin Dong et al.
FRONTIERS IN ONCOLOGY (2018)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells
Ling Xu et al.
MOLECULAR ONCOLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells
Xiao Zhang et al.
NUCLEIC ACIDS RESEARCH (2017)
MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells
Chaohui Zuo et al.
TUMOR BIOLOGY (2017)
Increased EGFR Phosphorylation Correlates with Higher Programmed Death Ligand-1 Expression: Analysis of TKI-Resistant Lung Cancer Cell Lines
Kenichi Suda et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
Goodwin G. Jinesh et al.
SCIENTIFIC REPORTS (2017)
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy
Silvia von Karstedt et al.
NATURE REVIEWS CANCER (2017)
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
Harshita B. Gupta et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells
Shingo Hamano et al.
CANCER LETTERS (2015)
Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions
Avi Ashkenazi
JOURNAL OF CLINICAL INVESTIGATION (2015)
Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
Abdullah Alsuliman et al.
MOLECULAR CANCER (2015)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita et al.
MOLECULAR THERAPY (2015)
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer
Young-Jun Jeon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells
Ling Xu et al.
ONCOLOGY REPORTS (2014)
Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts
Ling Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells
Ling Xu et al.
FEBS LETTERS (2013)
Molecular Pathways: Next-Generation Immunotherapy-Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Daniel S. Chen et al.
CLINICAL CANCER RESEARCH (2012)
TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells
Ling Xu et al.
EUROPEAN JOURNAL OF CANCER (2012)
Gene-protein correlation in single cells
Jaclyn J. Renfrow et al.
NEURO-ONCOLOGY (2011)
A Brief Review on the Mechanisms of miRNA Regulation
Yimei Cai et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2010)
Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
Hazem Ghebeh et al.
BREAST CANCER RESEARCH (2010)
Targeting apoptosis as an approach for gastrointestinal cancer therapy
Liang Qiao et al.
DRUG RESISTANCE UPDATES (2009)
TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them
Andrew Thorburn et al.
DRUG RESISTANCE UPDATES (2008)
分享论文
